Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
About Us
Conferences
Videos
Webinars
Media & Press
Whitepapers
Advertising
Site Map
2022
May
16
Accelerate commercializes blood culture kit
FDA OKs Labcorp's over-the-counter COVID-19, RSV, flu test
Artemis signs $250M deal for liquid biopsy tests with Datar
Qiagen expands QIAstat-Dx syndromic panel
LumiraDx reports revenue increases for Q1
Page 1 of 1